Literature DB >> 16874747

Anticipated uptake of genetic testing for familial melanoma in an Australian sample: An exploratory study.

Nadine A Kasparian1, Bettina Meiser, Phyllis N Butow, R F Soames Job, Graham J Mann.   

Abstract

INTRODUCTION: The potential role of genetic testing in families with an inherited pattern of melanoma is a complex issue, and yet limited data exist on perceptions of predictive genetic testing for mutations among individuals at high risk of melanoma.
METHODOLOGY: Forty semi-structured interviews were undertaken with affected and unaffected individuals at either high or average risk of developing melanoma due to family history. Interviews addressed key issues such as: the role of genetics in causal attributions for melanoma; genetic testing intentions and motivations; perceived accuracy of genetic testing in predicting melanoma onset, and the impact of varied accuracy on testing intentions; views on the testing of children; perceived benefits and limitations of testing; and information needs and communication preferences.
RESULTS: In-depth thematic analysis revealed a number of important qualitative differences between groups at varying risk of melanoma, and genders. Specifically, participants with a family history of melanoma believed genetic factors play an important role in melanoma causation; conveyed strong intentions to pursue genetic testing; and viewed the benefits of genetic testing as outweighing the limitations. Females appeared to endorse the testing of children more firmly than males, and males' intentions to pursue testing appeared more contingent on penetrance than females'. Across groups, the most preferred communication option was an informational video.
CONCLUSION: Those at high risk of melanoma due to family history express a strong interest in predictive genetic testing. Copyright 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2007        PMID: 16874747     DOI: 10.1002/pon.1052

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  8 in total

1.  Disclosing individual CDKN2A research results to melanoma survivors: interest, impact, and demands on researchers.

Authors:  Kurt D Christensen; J Scott Roberts; David I Shalowitz; Jessica N Everett; Scott Y H Kim; Leon Raskin; Stephen B Gruber
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-02-09       Impact factor: 4.254

2.  Perceived intrafamily melanoma risk communication.

Authors:  Lois J Loescher; Janice D Crist; Leilani A C L Siaki
Journal:  Cancer Nurs       Date:  2009 May-Jun       Impact factor: 2.592

3.  Skin cancer screening behaviours among individuals with a strong family history of malignant melanoma.

Authors:  N A Kasparian; J K McLoone; B Meiser; P N Butow; J M Simpson; G J Mann
Journal:  Br J Cancer       Date:  2010-10-26       Impact factor: 7.640

4.  On averages and peaks: how do people integrate attitudes about multiple diseases to reach a decision about multiplex genetic testing?

Authors:  Shoshana Shiloh; Christopher H Wade; J Scott Roberts; Sharon Hensley Alford; Barbara B Biesecker
Journal:  Med Decis Making       Date:  2012-11-05       Impact factor: 2.583

5.  What can interest tell us about uptake of genetic testing? Intention and behavior amongst smokers related to patients with lung cancer.

Authors:  S C Sanderson; S C O'Neill; L A Bastian; G Bepler; C M McBride
Journal:  Public Health Genomics       Date:  2009-06-29       Impact factor: 2.000

6.  Unaffected family members report improvements in daily routine sun protection 2 years following melanoma genetic testing.

Authors:  Lisa G Aspinwall; Jennifer M Taber; Wendy Kohlmann; Samantha L Leaf; Sancy A Leachman
Journal:  Genet Med       Date:  2014-04-24       Impact factor: 8.822

7.  Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma.

Authors:  Lauren G Aoude; Antonia L Pritchard; Carla Daniela Robles-Espinoza; Karin Wadt; Mark Harland; Jiyeon Choi; Michael Gartside; Víctor Quesada; Peter Johansson; Jane M Palmer; Andrew J Ramsay; Xijun Zhang; Kristine Jones; Judith Symmons; Elizabeth A Holland; Helen Schmid; Vanessa Bonazzi; Susan Woods; Ken Dutton-Regester; Mitchell S Stark; Helen Snowden; Remco van Doorn; Grant W Montgomery; Nicholas G Martin; Thomas M Keane; Carlos López-Otín; Anne-Marie Gerdes; Håkan Olsson; Christian Ingvar; Ake Borg; Nelleke A Gruis; Jeffrey M Trent; Göran Jönsson; D Timothy Bishop; Graham J Mann; Julia A Newton-Bishop; Kevin M Brown; David J Adams; Nicholas K Hayward
Journal:  J Natl Cancer Inst       Date:  2014-12-13       Impact factor: 13.506

8.  Management of melanoma families.

Authors:  Wilma Bergman; Nelleke A Gruis
Journal:  Cancers (Basel)       Date:  2010-04-16       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.